Covered recipient · General Payments record
KEVIN RUI ZHANG
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2024–2025
$4,054.08
- Reported across 40 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,395.32 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Vision LLC | $373.98 | 4 |
| ABBVIE INC. | $232.48 | 5 |
| GLAUKOS CORPORATION | $184.16 | 1 |
| Amgen Inc. | $174.37 | 2 |
| Sight Sciences, Inc. | $156.53 | 2 |
| Johnson & Johnson Surgical Vision, Inc. | $145.30 | 1 |
| Bausch & Lomb Americas Inc. | $111.98 | 1 |
| Oyster Point Pharma, Inc. | $16.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $131.57 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204857626 | CMS |
| ABBVIE INC. | $19.62 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204857630 | CMS |
| ABBVIE INC. | $30.91 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204857634 | CMS |
| ABBVIE INC. | $24.07 | 10/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204857638 | CMS |
| ABBVIE INC. | $26.31 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204857642 | CMS |
| Alcon Vision LLC | $147.65 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207456780 | CMS |
| Alcon Vision LLC | $137.77 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207456926 | CMS |
| Alcon Vision LLC | $55.18 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207456832 | CMS |
| Alcon Vision LLC | $33.38 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207456804 | CMS |
| Amgen Inc. | $106.21 | 03/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228312437 | CMS |
| Amgen Inc. | $68.16 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228312439 | CMS |
| Bausch & Lomb Americas Inc. | $111.98 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254823843 | CMS |
| Glaukos Corporation | $184.16 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246410016 | CMS |
| Johnson & Johnson Surgical Vision, Inc. | $145.30 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1173807567 | CMS |
| Oyster Point Pharma, Inc. | $16.52 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238395113 | CMS |
| Sight Sciences, Inc. | $107.20 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244656454 | CMS |
| Sight Sciences, Inc. | $49.33 | 08/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244663077 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.